3434 related articles for article (PubMed ID: 21163766)
21. Cocaine-induced acute renal failure, hemolysis, and thrombocytopenia mimicking thrombotic thrombocytopenic purpura.
Volcy J; Nzerue CM; Oderinde A; Hewan-Iowe K
Am J Kidney Dis; 2000 Jan; 35(1):E3. PubMed ID: 10620564
[TBL] [Abstract][Full Text] [Related]
22. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
23. [Differential diagnosis of DIC, TTP, and HUS].
Ozaki Y
Rinsho Byori; 2011 Feb; Suppl 147():195-8. PubMed ID: 21761771
[No Abstract] [Full Text] [Related]
24. Ketoconazole and Flutamide in the treatment of disseminated intravascular clotting from prostate cancer: a case report and review.
Chakrapee-Sirisuk S; Amornpichetkul K; Visudhiphan S; Sangruchi T; Srimuninnimit V; Sinlarat P
J Med Assoc Thai; 2001 Oct; 84(10):1495-501. PubMed ID: 11804262
[TBL] [Abstract][Full Text] [Related]
25. Pathophysiology and management of thrombotic microangiopathies.
Ruggenenti P; Remuzzi G
J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
[TBL] [Abstract][Full Text] [Related]
26. [Emergency blood picture].
Tobler A
Schweiz Med Wochenschr; 1993 Apr; 123(15):711-20. PubMed ID: 8488374
[TBL] [Abstract][Full Text] [Related]
27. Thrombotic thrombocytopenic purpura in advanced prostate cancer: case report and published work review.
Caramello V; Dovio A; Caraci P; Berruti A; Angeli A
Int J Urol; 2007 Feb; 14(2):150-2. PubMed ID: 17302573
[TBL] [Abstract][Full Text] [Related]
28. Coagulopathy in prostate cancer.
de la Fouchardière C; Flechon A; Droz JP
Neth J Med; 2003 Nov; 61(11):347-54. PubMed ID: 14768717
[TBL] [Abstract][Full Text] [Related]
29. Combined androgen blockade-induced anemia in prostate cancer patients without bone involvement.
Bogdanos J; Karamanolakis D; Milathianakis C; Repousis P; Tsintavis A; Koutsilieris M
Anticancer Res; 2003; 23(2C):1757-62. PubMed ID: 12820454
[TBL] [Abstract][Full Text] [Related]
30. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer.
Janoff DM; Peterson C; Mongoue-Tchokote S; Peters L; Beer TM; Wersinger EM; Mori M; Garzotto M
BJU Int; 2005 Sep; 96(4):503-7. PubMed ID: 16104900
[TBL] [Abstract][Full Text] [Related]
32. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
33. Advanced gastric cancer associated with DIC successfully treated with 5-FU and cisplatin: a case report.
Matsumoto S; Kiba T; Numata K; Ihata Y; Morita K; Kitamura T; Saito S; Nakatani Y; Tanaka K; Sekihara H
Hepatogastroenterology; 2002; 49(43):153-6. PubMed ID: 11941941
[TBL] [Abstract][Full Text] [Related]
34. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
Clark WF
Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
[TBL] [Abstract][Full Text] [Related]
35. A clinico-hematological profile of hemolytic-uremic syndrome.
Dayal R; Agarwal S; Prasad R; Mathur PP; Agarwal A; Anand A
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():280-3. PubMed ID: 7886599
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of disseminated intravascular coagulation.
Bakhshi S; Arya LS
Indian Pediatr; 2003 Aug; 40(8):721-30. PubMed ID: 12951374
[TBL] [Abstract][Full Text] [Related]
37. Hemolytic uremic syndrome in metastatic adenocarcinoma of the prostate.
Mungall S; Mathieson P
Am J Kidney Dis; 2002 Dec; 40(6):1334-6. PubMed ID: 12460056
[TBL] [Abstract][Full Text] [Related]
38. Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Monteagudo J; Pereira A; Reverter JC; Pijoan J; Tusell J; Puig L; Ordinas A; Castillo R
Thromb Haemost; 1991 Nov; 66(5):515-9. PubMed ID: 1803613
[TBL] [Abstract][Full Text] [Related]
39. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
40. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
Byrnes JJ; Moake JL
Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
